<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Endoscopic mucosal resection (EMR) and endoscopic ablation with porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> photodynamic therapy (<z:chebi fb="7" ids="53228">PDT</z:chebi>) have recently been combined to improve the accuracy of histologic staging and remove superficial <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> were evaluated with computed tomography and endosonography </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with nodular or irregular folds underwent EMR followed by <z:chebi fb="7" ids="53228">PDT</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In three patients, endoscopic mucosal resection upstaged the diagnosis to mucosal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (T1N0M0) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="7" ids="53228">PDT</z:chebi> successfully ablated the remaining glandular mucosa </plain></SENT>
<SENT sid="5" pm="."><plain>Complications were limited to transient chest discomfort and odynophagia </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The use of EMR resection in Barrett's high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> patients with mucosal irregularities resulted in histologic upstaging to mucosal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, requiring higher laser light doses for <z:chebi fb="7" ids="53228">PDT</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="7" ids="53228">PDT</z:chebi> after EMR appears to be safe and effective for the complete elimination of Barrett's mucosal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>EMR should be strongly considered for Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> patients being evaluated for endoscopic ablation therapy </plain></SENT>
</text></document>